Cargando…
Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
Metabolic regulation has been proven to play a critical role in T cell antitumor immunity. However, cholesterol metabolism as a key component of this regulation remains largely unexplored. Herein, we found that the low-density lipoprotein receptor (LDLR), which has been previously identified as a tr...
Autores principales: | Yuan, Juanjuan, Cai, Ting, Zheng, Xiaojun, Ren, Yangzi, Qi, Jingwen, Lu, Xiaofei, Chen, Huihui, Lin, Huizhen, Chen, Zijie, Liu, Mengnan, He, Shangwen, Chen, Qijun, Feng, Siyang, Wu, Yingjun, Zhang, Zhenhai, Ding, Yanqing, Yang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018994/ https://www.ncbi.nlm.nih.gov/pubmed/33606190 http://dx.doi.org/10.1007/s13238-021-00821-2 |
Ejemplares similares
-
Correction to: Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
por: Yuan, Juanjuan, et al.
Publicado: (2021) -
PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells
por: Lagace, Thomas A.
Publicado: (2014) -
PCSK9 Prosegment Chimera as Novel Inhibitors of LDLR Degradation
por: Luna Saavedra, Yascara Grisel, et al.
Publicado: (2013) -
PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021) -
The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)